v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Balance at beginning of period (in shares) at Dec. 31, 2020   113,128      
Balance at beginning of period at Dec. 31, 2020 $ 1,205,289 $ 113 $ 1,179,972 $ (4,732) $ 29,936
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 110,598       110,598
Other comprehensive income (loss) (8,797)     (8,797)  
Dividends declared (43,300)       (43,300)
Net issuances of restricted stock (in shares)   602      
Net issuances of restricted stock 0 $ 1 (1)    
Stock-based compensation 14,182   14,182    
Repurchases of common stock (in shares)   (1,048)      
Repurchases of common stock (80,273) $ (1)     (80,272)
Balance at end of period (in shares) at Mar. 31, 2021   112,682      
Balance at end of period at Mar. 31, 2021 1,197,699 $ 113 1,194,153 (13,529) 16,962
Balance at beginning of period (in shares) at Dec. 31, 2020   113,128      
Balance at beginning of period at Dec. 31, 2020 1,205,289 $ 113 1,179,972 (4,732) 29,936
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 430,682        
Other comprehensive income (loss) (14,368)        
Balance at end of period (in shares) at Sep. 30, 2021   111,229      
Balance at end of period at Sep. 30, 2021 1,316,043 $ 111 1,222,117 (19,100) 112,915
Balance at beginning of period (in shares) at Mar. 31, 2021   112,682      
Balance at beginning of period at Mar. 31, 2021 1,197,699 $ 113 1,194,153 (13,529) 16,962
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 149,213       149,213
Other comprehensive income (loss) 4,437     4,437  
Dividends declared (42,720)       (42,720)
Net issuances of restricted stock (in shares)   5      
Stock-based compensation 13,903   13,903    
Repurchases of common stock (in shares)   (717)      
Repurchases of common stock (63,282) $ (1)     (63,281)
Balance at end of period (in shares) at Jun. 30, 2021   111,970      
Balance at end of period at Jun. 30, 2021 1,259,250 $ 112 1,208,056 (9,092) 60,174
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 170,871       170,871
Other comprehensive income (loss) (10,008)     (10,008)  
Dividends declared (42,463)       (42,463)
Net issuances of restricted stock (in shares)   1      
Stock-based compensation 14,061   14,061    
Repurchases of common stock (in shares)   (742)      
Repurchases of common stock (75,668) $ (1)     (75,667)
Balance at end of period (in shares) at Sep. 30, 2021   111,229      
Balance at end of period at Sep. 30, 2021 1,316,043 $ 111 1,222,117 (19,100) 112,915
Balance at beginning of period (in shares) at Dec. 31, 2021   110,686      
Balance at beginning of period at Dec. 31, 2021 1,381,051 $ 111 1,235,903 (22,622) 167,659
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 168,239       168,239
Other comprehensive income (loss) (952)     (952)  
Dividends declared (48,413)       (48,413)
Net issuances of restricted stock (in shares)   598      
Net issuances of restricted stock 0 $ 1 (1)    
Stock-based compensation 15,184   15,184    
Repurchases of common stock (in shares)   (537)      
Repurchases of common stock (62,341) $ (1)     (62,340)
Balance at end of period (in shares) at Mar. 31, 2022   110,747      
Balance at end of period at Mar. 31, 2022 1,452,768 $ 111 1,251,086 (23,574) 225,145
Balance at beginning of period (in shares) at Dec. 31, 2021   110,686      
Balance at beginning of period at Dec. 31, 2021 1,381,051 $ 111 1,235,903 (22,622) 167,659
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 510,266        
Other comprehensive income (loss) (49,137)        
Balance at end of period (in shares) at Sep. 30, 2022   108,498      
Balance at end of period at Sep. 30, 2022 1,490,917 $ 108 1,279,576 (71,759) 282,992
Balance at beginning of period (in shares) at Mar. 31, 2022   110,747      
Balance at beginning of period at Mar. 31, 2022 1,452,768 $ 111 1,251,086 (23,574) 225,145
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 175,821       175,821
Other comprehensive income (loss) (24,033)     (24,033)  
Dividends declared (47,325)       (47,325)
Net issuances of restricted stock (in shares)   4      
Stock-based compensation 14,409   14,409    
Repurchases of common stock (in shares)   (1,144)      
Repurchases of common stock (103,972) $ (1)     (103,971)
Balance at end of period (in shares) at Jun. 30, 2022   109,607      
Balance at end of period at Jun. 30, 2022 1,467,668 $ 110 1,265,495 (47,607) 249,670
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 166,206       166,206
Other comprehensive income (loss) (24,152)     (24,152)  
Dividends declared (46,944)       (46,944)
Net issuances of restricted stock (in shares)   0      
Stock-based compensation 14,081   14,081    
Repurchases of common stock (in shares)   (1,109)      
Repurchases of common stock (85,942) $ (2)     (85,940)
Balance at end of period (in shares) at Sep. 30, 2022   108,498      
Balance at end of period at Sep. 30, 2022 $ 1,490,917 $ 108 $ 1,279,576 $ (71,759) $ 282,992